Researchers discover blood biomarker for Lou Gehrig's disease, could lead to new treatments
Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. This finding ...
Aug 6, 2012
0
0